Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Why Chewy Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket

Published 01/06/2023, 12:55
Updated 01/06/2023, 14:10
© Reuters.  Why Chewy Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket

Benzinga - Gainers

  • Airspan Networks Holdings Inc. (NYSE: MIMO) shares rose 58.9% to $0.3754 in pre-market trading. Airspan Networks recently reported new financing and leadership changes.
  • T2 Biosystems, Inc. (NASDAQ: TTOO) shares gained 50% to $0.1350 in pre-market trading after dropping 33% on Wednesday. T2 Biosystems recently announced the second-largest sepsis-driven T2Dx instruments sale in the company's history.
  • AGBA Group Holding Limited (NASDAQ: AGBA) shares surged 37.7% to $2.23 in pre-market trading after gaining around 9% on Wednesday.
  • Wejo Group Limited (NASDAQ: WEJO) gained 28.2% to $0.1090 in pre-market trading after declining around 31% on Wednesday. Wejo Group recently said it is evaluating whether to file ancillary insolvency proceedings for the company and other units in other jurisdictions, including the US.
  • VCI Global Limited (NASDAQ: VCIG) shares rose 28% to $3.47 in pre-market trading after gaining 7% on Wednesday. VCI Global said it will be subscribing for 500 new GlobexUS Holdings Corp shares at $3,000 per share for $1.5 million.
  • Hoth Therapeutics, Inc. (NASDAQ: HOTH) rose 24.1% to $1.96 in pre-market trading. EF Hutton assumed Buy rating and $14 price target on Hoth.
  • Chewy, Inc. (NYSE: CHWY) rose 17% to $34.50 in pre-market trading on the heels of a strong first-quarter report.
  • Apollomics, Inc. (NASDAQ: APLM) gained 15.1% to $4.66 in pre-market trading.
  • AstroNova, Inc. (NASDAQ: ALOT) shares climbed 12.5% to $17.97 in pre-market trading. AstroNova is expected to report its first-quarter fiscal 2024 financial results on June 8, 2023.
  • Kingsoft Cloud Holdings Limited (NASDAQ: KC) shares gained 10.6% to $4.94 in pre-market trading. The China-based technology firm recently reported a first-quarter FY23 revenue of $271.48 million, missing the consensus of $282.80 million.
Losers
  • C3.ai, Inc. (NYSE: AI) fell 20.4% to $31.85 in pre-market. C3.ai reported better-than-expected earnings and sales results for its first quarter. C3.ai also said it sees first-quarter revenue of $70 million to $72.5 million versus estimates of $71.56 million.
  • Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) shares dropped 19% to $0.3220 in pre-market trading. Aridis Pharmaceuticals shares jumped around 115% on Wednesday after the company announced it received agreement from the FDA on its proposed single confirmatory Phase 3 study of AR-301 and the clinical study design..
  • Okta, Inc. (NASDAQ: OKTA) shares dropped 19% to $73.50 in pre-market trading despite strong first-quarter results.
  • Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) fell 17.6% to $1.73 in pre-market trading after jumping 20% on Wednesday.
  • Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) fell 16.7% to $2.75 in pre-market trading after the company reported a proposed public offering of common stock.
  • VolitionRx Limited (NYSE: VNRX) fell 16.6% to $1.29 in pre-market trading after announcing a proposed underwritten public offering of common stock.
  • Victoria's Secret & Co. (NYSE: VSCO) shares fell 16% to $17.15 in pre-market trading after the company reported a sharp decline in first-quarter EPS.
  • IM Cannabis Corp. (NASDAQ: IMCC) fell 14.7% to $1.09 in pre-market trading after jumping around 20% on Wednesday.
  • QualTek Services Inc. (NASDAQ: QTEK) fell 13.7% to $0.0773 in pre-market trading. QualTek Services shares dropped over 40% on Wednesday after the company received a Nasdaq delisting notice.
  • VIQ Solutions Inc. (NASDAQ: VQS) fell 11.8% to $0.2644 in pre-market trading after gaining over 28% on Wednesday.

Now Read This: Investor Sentiment Drops As Dow Records Loss For May

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.